// App-Quantinova.ai

3873 : Thromboembolic and Hemorrhagic Complications In Adult Patients With Acute Lymphoblastic Leukemia (ALL) Treated With Asparaginase-Containing Combination Chemotherapy: A Single Center Experience

Researchers

Presenter

  • Jason N. Barreto

Principal Investigators

  • Kristen B. McCullough

  • Candy S. Peskey

  • Michelle Elliott

  • Dennis A. Gastineau

  • Aref Al-Kali

  • Louis Letendre

  • William Hogan

  • Mark Litzow

  • Mrinal M. Patnaik

Medical Centers

  • Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN

  • Department of Oncology, Mayo Clinic, Rochester, MN

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

  • Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute lymphoblastic leukemia

  • Deep vein thrombosis

  • Intracerebral hemorrhage

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • Autophagy-related gene 5

  • Breakpoint Cluster Region

Drug/Treatment

  • Asparaginase

  • Fibrinogen (IV)

  • Grace

Outcome

  • N/A

Study Design

  • observational

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved